The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 354:1848-1851 April 27, 2006 Number 17
NextNext

Hypertonic Saline for Cystic Fibrosis

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Ratjen, F.
-Related Article
 by Elkins, M. R.
-Related Article
 by Donaldson, S. H.
-PubMed Citation
To the Editor: We question the selection by Elkins et al.1 and Donaldson et al.2 (Jan. 19 issue) of 7 percent hypertonic saline, which can result in bronchoconstriction, in these studies of therapy for cystic fibrosis. Elkins et al. report a fall of 94 ml in the forced expiratory volume in one second (FEV1) after the first dose of medication, which is greater than the reported final improvement in FEV1 of 68 ml. Conversely, Donaldson et al. do not specify any change in FEV1 with the use of 7 percent hypertonic saline. Robinson et al.3 have compared mucociliary clearance . . . [Full Text of this Article]


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.